DURHAM, N.C. -- Duke Researchers received a $6 million grant today from the Pediatric Brain Tumor Foundation, the second grant from the Asheville-based foundation.

Discuss This Story

 

Since Duke received the initial $6 million grant five years ago, PBTF-funded research at Duke has focused on projects aimed at developing gene-based therapies, vaccines and other novel treatments for common childhood brain tumors, including medulloblastomas and astrocytomas. 

 

Researchers at Duke share their results with counterparts at the foundation’s three other institutes at Children’s Hospital Los Angeles; the Hospital for Sick Children in Toronto, Canada; and the University of California, San Francisco. 

 

Pediatric brain tumors are the leading cause of cancer death in children and adolescents. Four out of ten children with brain tumors die within five years of diagnosis.